Inflammatory Signatures in MDS: The Missing Link Between Genetics, Microenvironment, and Therapy.
Chronic age-related inflammation drives myelodysplastic syndrome development, pointing toward new drug targets beyond current standard therapies.
This review establishes a mechanistic framework connecting aging-associated chronic inflammation (inflammaging) with MDS pathogenesis via bone marrow microenvironment remodeling and immune dysregulation, positioning MDS as an inflammaging-driven disease. The synthesis identifies specific inflammatory signatures and mediators as potential therapeutic targets complementary to existing HMA therapy, with relevance to understanding why MDS is predominantly an age-related disease.
What the study was
- Study design
- Narrative/thematic review
- Population
- MDS patients; aging-related bone marrow microenvironment and inflammaging
- Category
- Genomics/Precision Medicine
- Maturity
- Exploratory
- Journal
- Cells
Why it surfaced
Synthesizes mechanistic links between aging/inflammaging and MDS pathogenesis; directly relevant to both the aging/longevity and hematologic malignancies watchlist topics, and identifies targetable inflammatory pathways in MDS.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.